January 4, 2018 Portfolio News from ARCH Venture Partners | Share Former Receptos Executives Launch Gossamer Bio, Inc., a New Biopharma Company Focused on Discovering and Developing a Pipeline of Novel and Differentiated Drug Candidates
December 11, 2017 Portfolio News from ARCH Venture Partners | Share Quanterix Corporation Announces Closing of Initial Public Offering
December 4, 2017 Portfolio News from ARCH Venture Partners | Share Denali Therapeutics Announces Closing Of Initial Public Offering, Including Full Exercise Of Underwriters’ Option To Purchase Additional Shares
